These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 30191143)

  • 1. Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target.
    Yao R; Zou H; Liao W
    Front Oncol; 2018; 8():332. PubMed ID: 30191143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma.
    Wang M; Yu F; Li P
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30072625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles.
    Aishanjiang K; Wei XD; Fu Y; Lin X; Ma Y; Le J; Han Q; Wang X; Kong X; Gu J; Wu H
    Front Oncol; 2021; 11():653717. PubMed ID: 33959506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma.
    Zhou S; Wei J; Wang Y; Liu X
    Exp Ther Med; 2020 Apr; 19(4):2733-2740. PubMed ID: 32226487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function.
    Hu J; Li P; Song Y; Ge YX; Meng XM; Huang C; Li J; Xu T
    J Cell Physiol; 2018 Jun; 233(6):4408-4422. PubMed ID: 28833094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression.
    Luo Y; Fu Y; Huang R; Gao M; Liu F; Gui R; Nie X
    Cell Death Discov; 2019; 5():121. PubMed ID: 31372241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma.
    Wang M; Wu M; Xie T; Chen J
    Front Genet; 2020; 11():628655. PubMed ID: 33679871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Zhang C; Zhang C; Lin J; Wang H
    Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.
    Zhang Y; Wang Y
    Front Oncol; 2021; 11():667428. PubMed ID: 34055634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma.
    Kou P; Zhang C; Lin J; Wang H
    Oncol Lett; 2019 Feb; 17(2):2091-2098. PubMed ID: 30675276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.
    Luo Z; Mao X; Cui W
    Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma.
    Huang Y; Ji H; Dong J; Wang X; He Z; Cheng Z; Zhu Q
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of up- and downregulation of circRNAs in HBV-related hepatocellular carcinoma by microarray.
    Cui S; Qian Z; Chen Y; Li L; Li P; Ding H
    Oncol Lett; 2018 Jan; 15(1):423-432. PubMed ID: 29387227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma.
    Huang Z; Xia H; Liu S; Zhao X; He R; Wang Z; Shi W; Chen W; Kang P; Su Z; Cui Y; Yam JWP; Xu Y
    Front Oncol; 2021; 11():714665. PubMed ID: 34540684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma.
    Xiong D; He R; Dang Y; Wu H; Feng Z; Chen G
    Front Oncol; 2020; 10():608257. PubMed ID: 33680930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Circular RNAs in Hepatocellular Carcinoma.
    Qiu LP; Wu YH; Yu XF; Tang Q; Chen L; Chen KP
    J Cancer; 2018; 9(9):1548-1559. PubMed ID: 29760792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production.
    Dong W; Dai ZH; Liu FC; Guo XG; Ge CM; Ding J; Liu H; Yang F
    EBioMedicine; 2019 Jul; 45():155-167. PubMed ID: 31235426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis.
    Jiang YL; Shang MM; Dong SZ; Chang YC
    World J Gastrointest Oncol; 2019 Oct; 11(10):909-924. PubMed ID: 31662829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.